Efficacy and Safety of Mirabegron in Men with Overactive Bladder Symptoms and Benign Prostatic Hyperplasia

Current Urology Reports ◽

10.1007/s11934-020-01017-7 ◽

2021 ◽

Vol 22 (1) ◽

Author(s):

Gregory R. Mullen ◽

Steven A. Kaplan

Keyword(s):

Benign Prostatic Hyperplasia ◽

Overactive Bladder ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Overactive Bladder Symptoms ◽

Bladder Symptoms

Download Full-text

LBA-03 EFFICACY AND SAFETY OF MIRABEGRON VS. PLACEBO ADD-ON THERAPY IN MEN WITH OVERACTIVE BLADDER SYMPTOMS RECEIVING TAMSULOSIN FOR UNDERLYING BENIGN PROSTATIC HYPERPLASIA (PLUS)

The Journal of Urology ◽

10.1097/01.ju.0000557495.41260.09 ◽

2019 ◽

Vol 201 (Supplement 4) ◽

Author(s):

Steven Kaplan* ◽

Sender Herschorn ◽

Kevin McVary ◽

David Staskin ◽

Christopher Chapple ◽

...

Keyword(s):

Benign Prostatic Hyperplasia ◽

Overactive Bladder ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Overactive Bladder Symptoms ◽

Bladder Symptoms

Download Full-text

Efficacy and safety of combination therapy with tamsulosin, dutasteride and imidafenacin for the management of overactive bladder symptoms associated with benign prostatic hyperplasia: A multicenter, randomized, open-label, controlled trial (DIrecT Study)

International Journal of Urology ◽

10.1111/iju.13359 ◽

2017 ◽

Vol 24 (7) ◽

pp. 525-531 ◽

Author(s):

Tomonori Yamanishi ◽

Hirotaka Asakura ◽

Narihito Seki ◽

Shoji Tokunaga

Keyword(s):

Benign Prostatic Hyperplasia ◽

Overactive Bladder ◽

Combination Therapy ◽

Controlled Trial ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Direct Study ◽

Overactive Bladder Symptoms ◽

Bladder Symptoms

Download Full-text

The Efficacy and Safety of Combination Therapy with Alpha-Blocker and Low-Dose Propiverine Hydrochloride for Benign Prostatic Hyperplasia Accompanied by Overactive Bladder Symptoms

Korean Journal of Urology ◽

10.4111/kju.2009.50.11.1078 ◽

2009 ◽

Vol 50 (11) ◽

pp. 1078 ◽

Author(s):

Kang Il Seo ◽

Sung Zoo Hong ◽

Jong Bouk Lee

Keyword(s):

Benign Prostatic Hyperplasia ◽

Overactive Bladder ◽

Combination Therapy ◽

Low Dose ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Alpha Blocker ◽

Overactive Bladder Symptoms ◽

Bladder Symptoms

Download Full-text

Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS)

The Journal of Urology ◽

10.1097/ju.0000000000000738 ◽

2020 ◽

Vol 203 (6) ◽

pp. 1163-1171 ◽

Author(s):

Steven A. Kaplan ◽

Sender Herschorn ◽

Kevin T. McVary ◽

David Staskin ◽

Christopher Chapple ◽

...

Keyword(s):

Benign Prostatic Hyperplasia ◽

Overactive Bladder ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Overactive Bladder Symptoms ◽

Bladder Symptoms

Download Full-text

A 52‐week multicenter randomized controlled study of the efficacy and safety of add‐on dutasteride and imidafenacin to tamsulosin in patients with benign prostatic hyperplasia with remaining overactive bladder symptoms (DIrecT study)

LUTS Lower Urinary Tract Symptoms ◽

10.1111/luts.12243 ◽

2018 ◽

Vol 11 (3) ◽

pp. 115-121 ◽

Author(s):

Tomonori Yamanishi ◽

Hirotaka Asakura ◽

Narihito Seki ◽

Shoji Tokunaga

Keyword(s):

Benign Prostatic Hyperplasia ◽

Overactive Bladder ◽

Prostatic Hyperplasia ◽

Randomized Controlled Study ◽

Controlled Study ◽

Efficacy And Safety ◽

Direct Study ◽

Randomized Controlled ◽

Overactive Bladder Symptoms ◽

Bladder Symptoms

Download Full-text

Solifenacin or Mirabegron Could Improve Persistent Overactive Bladder Symptoms After Dutasteride Treatment in Patients With Benign Prostatic Hyperplasia

Urology ◽

10.1016/j.urology.2015.01.028 ◽

2015 ◽

Vol 85 (5) ◽

pp. 1151-1155 ◽

Author(s):

Takahiro Maeda ◽

Eiji Kikuchi ◽

Masanori Hasegawa ◽

Katsura Ishioka ◽

Masayuki Hagiwara ◽

...

Keyword(s):

Benign Prostatic Hyperplasia ◽

Overactive Bladder ◽

Prostatic Hyperplasia ◽

Overactive Bladder Symptoms ◽

Bladder Symptoms

Download Full-text

Effect of systemic atherosclerosis on overactive bladder symptoms in men with benign prostatic hyperplasia

LUTS Lower Urinary Tract Symptoms ◽

10.1111/luts.12406 ◽

2021 ◽

Author(s):

Dongu Lee ◽

Kyo Chul Koo ◽

Jeong Woo Yoo ◽

Kwang Suk Lee

Keyword(s):

Benign Prostatic Hyperplasia ◽

Overactive Bladder ◽

Prostatic Hyperplasia ◽

Overactive Bladder Symptoms ◽

Bladder Symptoms

Download Full-text

MP-01.01: The effect of anticholinergics to benign prostatic hyperplasia patients with overactive bladder symptoms and the risk factors to affect patient's satisfaction

Urology ◽

10.1016/j.urology.2010.07.345 ◽

2010 ◽

Vol 76 (3) ◽

pp. S9

Author(s):

W. Cho ◽

T. Kim ◽

J. Yoon

Keyword(s):

Risk Factors ◽

Benign Prostatic Hyperplasia ◽

Overactive Bladder ◽

Prostatic Hyperplasia ◽

Patient’S Satisfaction ◽

Overactive Bladder Symptoms ◽

Bladder Symptoms

Download Full-text

Efficacy of adding mirabegron to alpha-adrenoreceptor blocker in patients with benign prostatic hyperplasia with persistent overactive bladder symptoms: A prospective study

Investigative and Clinical Urology ◽

10.4111/icu.2020.61.4.419 ◽

2020 ◽

Vol 61 (4) ◽

pp. 419

Author(s):

Se Yun Kwon ◽

Dong Jin Park ◽

Young Jin Seo ◽

Kyung Seop Lee

Keyword(s):

Benign Prostatic Hyperplasia ◽

Overactive Bladder ◽

Prospective Study ◽

Prostatic Hyperplasia ◽

Overactive Bladder Symptoms ◽

Bladder Symptoms ◽

A Prospective Study

Download Full-text

Clinical efficacy of an α1A/D-adrenoceptor blocker (naftopidil) on overactive bladder symptoms in patients with benign prostatic hyperplasia

International Journal of Urology ◽

10.1111/j.1442-2042.2006.01222.x ◽

2006 ◽

Vol 13 (1) ◽

pp. 15-20 ◽

Author(s):

SATORU TAKAHASHI ◽

ATSUSHI TAJIMA ◽

HISASHI MATSUSHIMA ◽

TAKESHI KAWAMURA ◽

TAKASHI TOMINAGA ◽

...

Keyword(s):

Benign Prostatic Hyperplasia ◽

Overactive Bladder ◽

Clinical Efficacy ◽

Prostatic Hyperplasia ◽

Overactive Bladder Symptoms ◽

Adrenoceptor Blocker ◽

Bladder Symptoms

Download Full-text